INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

COLLEGIUM PHARMACEUTICAL, INC

Filed

April 1, 2022

Period of Report

March 23, 2022

Accession Number

0001062993-22-009191